These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 17999561)

  • 1. Preclinical results with I(f) current inhibition by ivabradine.
    Berdeaux A
    Drugs; 2007; 67 Suppl 2():25-33. PubMed ID: 17999561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure.
    Mulder P; Barbier S; Chagraoui A; Richard V; Henry JP; Lallemand F; Renet S; Lerebours G; Mahlberg-Gaudin F; Thuillez C
    Circulation; 2004 Apr; 109(13):1674-9. PubMed ID: 14981003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The funny current: cellular basis for the control of heart rate.
    DiFrancesco D; Borer JS
    Drugs; 2007; 67 Suppl 2():15-24. PubMed ID: 17999560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ivabradine: cardiovascular effects.
    Rognoni A; Bertolazzi M; Macciò S; Rognoni G
    Recent Pat Cardiovasc Drug Discov; 2009 Jan; 4(1):61-6. PubMed ID: 19149708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversing dobutamine-induced tachycardia using ivabradine increases stroke volume with neutral effect on cardiac energetics in left ventricular post-ischaemia dysfunction.
    Bakkehaug JP; Naesheim T; Torgersen Engstad E; Kildal AB; Myrmel T; How OJ
    Acta Physiol (Oxf); 2016 Oct; 218(2):78-88. PubMed ID: 27145482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term treatment with ivabradine in post-myocardial infarcted rats counteracts f-channel overexpression.
    Suffredini S; Stillitano F; Comini L; Bouly M; Brogioni S; Ceconi C; Ferrari R; Mugelli A; Cerbai E
    Br J Pharmacol; 2012 Mar; 165(5):1457-66. PubMed ID: 21838751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ivabradine prevents deleterious effects of dopamine therapy in heart failure: No role for HCN4 overexpression.
    Paterek A; Sochanowicz B; Oknińska M; Śmigielski W; Kruszewski M; Mackiewicz U; Mączewski M; Leszek P
    Biomed Pharmacother; 2021 Apr; 136():111250. PubMed ID: 33450487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific inhibition of HCN channels slows rhythm differently in atria, ventricle and outflow tract and stabilizes conduction in the anoxic-reoxygenated embryonic heart model.
    Sarre A; Pedretti S; Gardier S; Raddatz E
    Pharmacol Res; 2010 Jan; 61(1):85-91. PubMed ID: 19818405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ivabradine: in adults with chronic heart failure with reduced left ventricular ejection fraction.
    Perry CM
    Am J Cardiovasc Drugs; 2012 Dec; 12(6):415-26. PubMed ID: 23181944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The discovery of the selective I(f) current inhibitor ivabradine. A new therapeutic approach to ischemic heart disease.
    Vilaine JP
    Pharmacol Res; 2006 May; 53(5):424-34. PubMed ID: 16638639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Chronic Heart Rate Reduction by I(f) Current Inhibitor Ivabradine on Left Ventricular Remodeling and Systolic Performance in Middle-Aged Rats With Postmyocardial Infarction Heart Failure.
    Dedkov EI; Bogatyryov Y; McCooey DS; Christensen LP; Weiss RM; Tomanek RJ
    J Cardiovasc Pharmacol Ther; 2015 May; 20(3):299-312. PubMed ID: 25287895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effects of delayed ivabradine treatment on cardiac anatomical and electrical remodeling in rat severe chronic heart failure.
    Milliez P; Messaoudi S; Nehme J; Rodriguez C; Samuel JL; Delcayre C
    Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H435-41. PubMed ID: 19074674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective and specific I(f) inhibition with ivabradine: new perspectives for the treatment of cardiovascular disease.
    Ferrari R; Ceconi C
    Expert Rev Cardiovasc Ther; 2011 Aug; 9(8):959-73. PubMed ID: 21878041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart rate reduction with ivabradine prevents thyroid hormone-induced cardiac remodeling in rat.
    Kim BH; Cho KI; Kim SM; Kim N; Han J; Kim JY; Kim IJ
    Heart Vessels; 2013 Jul; 28(4):524-35. PubMed ID: 23142972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart rate reduction with ivabradine prevents the global phenotype of left ventricular remodeling.
    Ceconi C; Comini L; Suffredini S; Stillitano F; Bouly M; Cerbai E; Mugelli A; Ferrari R
    Am J Physiol Heart Circ Physiol; 2011 Jan; 300(1):H366-73. PubMed ID: 20952661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart rate slowing for myocardial dysfunction/heart failure.
    Mulder P; Thuillez C
    Adv Cardiol; 2006; 43():97-105. PubMed ID: 16936475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reducing elevated heart rate in patients with multiple organ dysfunction syndrome by the I (f) (funny channel current) inhibitor ivabradine : MODI (f)Y trial.
    Nuding S; Ebelt H; Hoke RS; Krummenerl A; Wienke A; Müller-Werdan U; Werdan K
    Clin Res Cardiol; 2011 Oct; 100(10):915-23. PubMed ID: 21638157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart rate reduction with ivabradine improves energy metabolism and mechanical function of isolated ischaemic rabbit heart.
    Ceconi C; Cargnoni A; Francolini G; Parinello G; Ferrari R
    Cardiovasc Res; 2009 Oct; 84(1):72-82. PubMed ID: 19477966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac pacemaker I(f) current and its inhibition by heart rate-reducing agents.
    DiFrancesco D
    Curr Med Res Opin; 2005 Jul; 21(7):1115-22. PubMed ID: 16004681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel If current inhibitor ivabradine: safety considerations.
    Savelieva I; Camm AJ
    Adv Cardiol; 2006; 43():79-96. PubMed ID: 16936474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.